{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:24:55Z","timestamp":1787005495320,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1067\/mai.2003.1384","type":"journal-article","created":{"date-parts":[[2003,5,13]],"date-time":"2003-05-13T01:27:45Z","timestamp":1052789265000},"page":"763-769","source":"Crossref","is-referenced-by-count":56,"title":["Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis"],"prefix":"10.1067","volume":"111","author":[{"given":"Ulrich","family":"Wahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli O.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Albert F.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek L.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Decosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Hedlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Scheinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Rosado Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Baena-Cagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Estelle R. Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ruuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2003.1384_bib1","first-page":"437","article-title":"H1-antihistamines in children","author":"Simons","year":"2002"},{"key":"10.1067\/mai.2003.1384_bib2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(97)07302-9","article-title":"Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC","volume":"351","author":"The International Study of Asthma and Allergies in Childhood ISAAC Steering Committee","year":"1998","journal-title":"Lancet"},{"issue":"5 Pt 2","key":"10.1067\/mai.2003.1384_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0091-6749(95)70213-X","article-title":"An overview of current pharmacotherapy in perennial rhinitis","volume":"95","author":"Meltzer","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"1 pt 1","key":"10.1067\/mai.2003.1384_bib4","first-page":"22","article-title":"A cost of illness study of allergic rhinitis in the United States","volume":"99","author":"Malone","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib5","first-page":"121","article-title":"Seasonal allergic rhinitis and antihistamine effects on children's learning","volume":"71","author":"Vuurman","year":"1993","journal-title":"Ann Allergy"},{"issue":"5 suppl","key":"10.1067\/mai.2003.1384_bib6","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1067\/mai.2000.110151","article-title":"Epidemiologic evidence for asthma and rhinitis comorbidity","volume":"106","author":"Leynaert","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2500\/108854199778339053","article-title":"Complications of allergic rhinitis","volume":"20","author":"Settipane","year":"1999","journal-title":"Allergy Asthma Proc"},{"issue":"1 suppl","key":"10.1067\/mai.2003.1384_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1067\/mai.2001.115566","article-title":"Quality of life in adults and children with allergic rhinitis","volume":"108","author":"Meltzer","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0091-6749(98)70171-X","article-title":"Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids","volume":"101","author":"Craig","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/pai.1997.11.193","article-title":"Control of allergic rhinitis with antihistamines may prevent the onset or recurrence of otitis media","volume":"11","author":"Skoner","year":"1997","journal-title":"Pediatr Asthma Allergy Immunol"},{"issue":"5 Pt 2","key":"10.1067\/mai.2003.1384_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0091-6749(88)90036-X","article-title":"The role of nasal airway obstruction in sinus disease and facial development","volume":"82","author":"Shapiro","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2500\/108854196778996895","article-title":"Learning impariment and allergic rhinitis","volume":"17","author":"Simons","year":"1996","journal-title":"Allergy Asthma Proc"},{"key":"10.1067\/mai.2003.1384_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/000992289703600405","article-title":"Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study","author":"Pearlman","year":"1997","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1067\/mai.2003.1384_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1365-2222.1997.tb01153.x","article-title":"Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity","volume":"27","author":"Ciprandi","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2003.1384_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF03259210","article-title":"Cetirizine in children with chronic allergic rhinitis: a multicentre double-blind study of two doses of cetirizine and placebo","volume":"4","author":"Baelde","year":"1992","journal-title":"Drug Invest"},{"issue":"4 suppl","key":"10.1067\/mai.2003.1384_bib16","first-page":"47","article-title":"A placebo-controlled trial of cetirizine in seasonal allergic rhino-conjunctivitis in children aged 6 to 12 years","volume":"4","author":"Masi","year":"1993","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1067\/mai.2003.1384_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/pai.1996.10.9","article-title":"Treatment of seasonal allergic rhinitis in children with cetirizine or chlorpheniramine: a multicenter study","volume":"10","author":"Tinkelman","year":"1996","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"10.1067\/mai.2003.1384_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2125.1998.00657.x","article-title":"Loratadine-pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial","volume":"45","author":"Serra","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1067\/mai.2003.1384_bib19","first-page":"841","article-title":"Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age","volume":"47","author":"Wober","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1067\/mai.2003.1384_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0091-6749(99)70070-9","article-title":"Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120mg and 180 mg once-daily) and cetirizine in seasonal allergic rhinitis","volume":"104","author":"Howarth","year":"1999","journal-title":"J Allergy Clin Immunology"},{"key":"10.1067\/mai.2003.1384_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2500\/108854199778553046","article-title":"Safety and efficacy of once-daily fexofen-adine HCl in the treatment of autumn seasonal allergic rhinitis","volume":"20","author":"Casale","year":"1999","journal-title":"Allergy Asthma Proc"},{"issue":"suppl 63","key":"10.1067\/mai.2003.1384_bib23","first-page":"281","article-title":"fexofenadine and loratadine exhibit rapid onset of relief, but only fexofenadine maintains efficacy over a 2-week study period","volume":"55","author":"Mosges","year":"2000","journal-title":"Allergy"},{"issue":"6 Pt 1","key":"10.1067\/mai.2003.1384_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0091-6749(96)80192-8","article-title":"The clinical pharmacology of fexofenadine in children","volume":"98","author":"Simons","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1081-1206(10)62317-4","article-title":"Safety of fexofenadine in children treated for seasonal allergic rhinitis","volume":"87","author":"Graft","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5 suppl","key":"10.1067\/mai.2003.1384_bib26","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"World Health Organization. Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"10.1067\/mai.2003.1384_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0091-6749(97)70274-4","article-title":"Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma","volume":"100","author":"Corren","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1398-9995.2001.00629.x","article-title":"Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma","volume":"56","author":"Aubier","year":"2001","journal-title":"Allergy"},{"key":"10.1067\/mai.2003.1384_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1067\/mai.2000.da0470005","article-title":"The importance of allergens in the development of asthma and the persistence of symptoms","volume":"47","author":"Nelson","year":"2001","journal-title":"Dis Mon"},{"key":"10.1067\/mai.2003.1384_bib30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mai.2001.120015","article-title":"A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' post-treatment follow-up","volume":"108","author":"Warner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib31","first-page":"406","article-title":"Histamine levels and nasal cytology in children with chronic otitis media and rhinitis","volume":"74","author":"Meltzer","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2003.1384_bib32","first-page":"237","article-title":"Nasal patency in children with allergic rhinitis: correlation of objective and subjective assessments","volume":"74","author":"Watson","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2003.1384_bib33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2222.2000.00914.x","article-title":"Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis","volume":"30","author":"Van Cauwenberge","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2003.1384_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0091-6749(98)70256-8","article-title":"Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis","volume":"101","author":"Abdelaziz","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2003.1384_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000053725","article-title":"Histamine-induced activation of human lung macrophages","volume":"124","author":"Marone","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1067\/mai.2003.1384_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1081-1206(10)62712-3","article-title":"Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines","volume":"81","author":"Paolieri","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2003.1384_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1081-1206(10)62354-X","article-title":"Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast","volume":"86","author":"Simons","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2003.1384_bib38","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.4049\/jimmunol.166.6.4083","article-title":"Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors","volume":"266","author":"Triggiani","year":"2001","journal-title":"J Immunol"},{"issue":"suppl 3","key":"10.1067\/mai.2003.1384_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2222.1999.0290s3163.x","article-title":"The systematic safety of fexofenadine HCI","volume":"29","author":"Mason","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2003.1384_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00044011-199918040-00008","article-title":"The long-term safety and tolerability of fexofenadine in healthy subjects","volume":"18","author":"Nathan","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1067\/mai.2003.1384_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0009-9236(98)90052-2","article-title":"Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers","volume":"64","author":"Russell","year":"1998","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903008467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903008467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T08:24:16Z","timestamp":1553156656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674903008467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0091674903008467"],"URL":"https:\/\/doi.org\/10.1067\/mai.2003.1384","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}